The National Guidance for doctors assessing workers exposed to respirable crystalline silica dust with specific reference to the occupational respiratory diseases associated with engineered stone (the National Guidance) has been finalised and is now available on the Department of Health website. The National Guidance is designed to help GPs and medical practitioners identify and assess people at risk of silicosis caused by exposure to respirable crystalline silica (RSC) dust.
In 2019, the National Dust Disease Taskforce (the Taskforce) was established to develop a national approach to the prevention, early identification, control, and management of occupational dust diseases. The establishment of the Taskforce was in response to the re-emergence over the past decade of silicosis, an entirely preventable occupational respiratory disease that was prevalent in Australia in the 1940s to 1960s.
The re-emergence of silicosis has been mostly driven by the popularity of engineered stone material which has been available in Australia since the early 2000s. Engineered stone is manufactured stone with a high silica content used primarily in Australia for benchtops. Nearly one in four workers exposed to respirable crystalline silica dust from engineered stone before 2018, have been diagnosed with silicosis.
In its interim advice, the National Dust Disease Taskforce recommended the development of National Guidance to assist medical practitioners identify people at risk from RSC exposure, and improve the quality, frequency and coverage of health screening assessments for current and former workers.
To develop the National Guidance, the Taskforce established the National Guidance Working Group (the Working Group). The Working Group included medical experts from across a range of relevant fields covering respiratory and thoracic medicine, radiology, environmental and occupational medicine, and work health and safety. In developing the National Guidance, the Working Group collaborated extensively with the medical community including a wide range of medical specialists and interested parties. The National Guidance includes the latest research and the best available evidence to support medical practitioners make informed assessments of at-risk workers and provide support to achieve improved health outcomes.
Early this year, the Working Group finalised the National Guidance. The Royal Australasian College of Physicians (RACP), the Thoracic Society of Australia and New Zealand (TSANZ), the Australian College of Rural and Remote Medicine (ACRRM), and the Royal Australian and New Zealand College of Radiologists (RANZCR) have provided endorsement. The National Guidance is currently being considered by the Royal Australian College of General Practitioners (RACGP) for approval as a clinical resource.
The Department will regularly review and update the National Guidance documentation to ensure that it remains relevant and reflects the most up to date research and practice.
If you would like further information or have any questions about the Taskforce’s work, you can contact the Department of Health Dust Disease Policy and Projects Section at Dust@Health.gov.au
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Launch of new Australian Guideline for assessing and managing cardiovascular disease risk The 2023 Australian Guideline for assessing and managing cardiovascular disease risk, and associated Australian cardiovascular disease risk calculator (Aus CVD Risk Calculator), will become the new standard of care for the primary prevention of CVD in Australia. This…
At CESPHN we value your feedback and invite you to complete the 2023 stakeholder engagement survey At CESPHN, we value your feedback and invite you to complete the stakeholder engagement survey on our service delivery and communication over the past 12 months. This short survey only takes five minutes and…
CESPHN Healthy Ageing Strategy 2023-28 has been released The Central and Eastern Sydney PHN has developed a Healthy Ageing Strategy to empower older people in our region to live more active and fulfilling lives, enabled by inclusive communities, and supported by integrated person-centred health and social services. Healthy ageing relies…
NSW community urged to be on alert amid rise in listeriosis NSW Health is reminding people who are immunocompromised, pregnant, or aged over 65 years to avoid foods that can cause listeriosis, following several confirmed cases of listeria infection in NSW. Listeriosis infection, which comes from consuming food contaminated with…
CESPHN Primary Health Awards: 2023 Finalists and Winners announced At a packed event last night at the Hazelhurst Arts Centre in Gymea, CESPHN held its annual Primary Health Awards. CESPHN’s multicultural community was reflected in our numerous and diverse submissions. All immensely impressive. The winners, announced at the awards event,…